Director James L Bierman sold 13,836 shares (−25.0% of holdings) at $159.35–$160.00 on 2025-05-23 for $2.2M.
James L Bierman, a director of Tenet Healthcare, executed two separate sales on 2025-05-23, reducing his holdings from 55,271 shares to 41,435 shares. The sales totaled 13,836 shares at a blended average price of $159.58, generating $2,208,016.60. The company's current stock price is $165.10, above the transaction prices and near its 52-week high of $168.66. With a P/E of 6.52 and quarterly revenue of $5,223,000,000.00, Tenet trades at relatively modest multiples. The sale represents a material reduction in Bierman's personal stake but occurs in a context of strong recent price momentum (30-day change: +35.2%; 90-day change: +25.3%), making the timing of this divestiture a point for investors to consider.